|
⚲
|
| Keyboard |
| Saks Samuel R
✚
|
|
|---|---|
| CIK # | 0001365615 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001365615] | |
| 4 | [0001365615] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Saks Samuel R | |
| Protagonist Therapeutics Inc | |
| PDL Biopharma Inc | |
| Tonix Pharmaceuticals Holding Corp | |
| Depomed Inc | |
| Auspex Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2021-02-26 | Grant | 90,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2021-02-26 | Grant | 12,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2020-02-28 | Grant | 85,000 | $0.00 | |
|
PDL Biopharma Inc PDLI
Stock Option (right to buy) · derivative
|
2019-06-20 | Grant | 126,050 | $3.00 | 378,150 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2019-05-15 | Grant | 45,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2019-02-28 | Grant | 15,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2019-02-28 | Grant | 2,500 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2018-06-12 | Grant | 20,000 | $0.00 | |
|
PDL Biopharma Inc PDLI
Common stock
|
2018-06-08 | Grant | 54,348 | $2.76 | 150,000 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2018-05-31 | Grant | 50,000 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2017-06-20 | Grant | 20,000 | $0.00 | |
|
PDL Biopharma Inc PDLI
Common stock
|
2017-06-09 | Grant | 60,729 | $2.47 | 150,001 |
|
Tonix Pharmaceuticals Holding Corp TNXP
Common Stock, $0.001 par value
|
2017-05-27 | Option exercise | 750 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Restricted Stock Units · derivative
|
2017-05-27 | Option exercise | 750 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Common Stock, $0.001 par value
|
2017-02-09 | Option exercise | 750 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Restricted Stock Units · derivative
|
2017-02-09 | Option exercise | 750 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Common Stock, $0.001 par value
|
2016-06-21 | Buy | 25,000 | $2.00 | 50,000 |
|
PDL Biopharma Inc PDLI
Common stock
|
2016-06-02 | Grant | 71,023 | $3.52 | 250,001 |
|
Tonix Pharmaceuticals Holding Corp TNXP
Restricted Stock Unit · derivative
|
2016-05-27 | Grant | 7,500 | $0.00 | |
|
Depomed Inc DEPO
Restricted Stock Units · derivative
|
2016-05-18 | Grant | 3,131 | $0.00 | |
| showing 20 of 53 most recent transactions | |||||